v3.26.1
Cover
6 Months Ended
Jun. 30, 2025
shares
Cover [Abstract]  
Entity Registrant Name GOLDENWELL BIOTECH, INC.
Entity Central Index Key 0001800373
Document Type 10-Q/A
Amendment Flag true
Current Fiscal Year End Date --12-31
Entity Small Business true
Entity Shell Company false
Entity Emerging Growth Company true
Entity Current Reporting Status Yes
Document Period End Date Jun. 30, 2025
Entity Filer Category Non-accelerated Filer
Document Fiscal Period Focus Q2
Document Fiscal Year Focus 2025
Entity Ex Transition Period false
Entity Common Stock Shares Outstanding 99,000,000
Document Quarterly Report true
Document Transition Report false
Entity File Number 000-56275
Entity Incorporation State Country Code NV
Entity Tax Identification Number 84-2896086
Entity Address Address Line 1 581 Boston Mills Road
Entity Address Address Line 2 Suite 300
Entity Address City Or Town Hudson
Entity Address State Or Province OH
Entity Address Postal Zip Code 44087
City Area Code 440
Local Phone Number 666-7999
Entity Interactive Data Current Yes
Amendment Description On May 27, 2026, Goldenwell Biotech, Inc. (the “Company”), filed a Current Report on Form 8-K, disclosing, among other things, that the financial statements disclosed in the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2025 (the “June 30, 2025 Form 10-Q”), filed with the Securities and Exchange Commission (the “SEC”) on May 27, 2025, could no longer be relied upon. This Amendment No. 1 to Quarterly Report on Form 10-Q for the quarter ended June 30, 2025, fully restates the Company’s financial statements for the fiscal quarter ended June 30, 2025, and its related notes to financial statements and related disclosures in Item 2 (Management’s Discussion and Analysis of Financial Condition and Results of Operations).